Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function
The specific role of lysophosphatidic acid 2 (LPA2) in deep vein thrombosis (DVT) remains unclear.
Saved in:
Main Authors: | Bai Ruifeng, Yue Xinyang, Tian Xuan, Zhao Huiru, Liu Ying, Li Tian, Wu Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2025-02-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2024-1137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deep vein thrombosis secondary to an ovarian tumor – approach in low resource settings: A case report
by: Korel Antonio Hernandez López, et al.
Published: (2024-03-01) -
Analysis of early results of edoxaban and warfarin in the treatment of deep vein thrombosis
by: Abdullah Guner, et al.
Published: (2024-03-01) -
Antiphospholipid Syndrome as a Cause of Recurrent Portal Vein Thrombosis in a Man with a Medical History of other Thrombosis
by: R. G. Sayfutdinov, et al.
Published: (2023-05-01) -
Analysis of long noncoding gene expression and its interactions with protein-coding genes in vascular endothelial cells in keloids
by: Yunxiang Luo, et al.
Published: (2025-02-01) -
Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases
by: O. V. Khlynova, et al.
Published: (2018-11-01)